Relapsed Or Refractory Al Amyloidosis clinical trials

Explore recruiting relapsed or refractory al amyloidosis clinical trials.

Recruiting relapsed or refractory al amyloidosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Or Refractory Al Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 2 study of Belantamab Mafodotin in patients with relapsed or refractory AL amyloidosis

Netherlands, Germany, Greece, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2 Study of Linvoseltamab in Patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Spain, Greece

Phase I and Phase II (Integrated)- Other EU CTIS Study details

CLonE-specific CAR T-Cell therapy in relapsed or refractory AL amyloidosis - a single-center Phase I trial (CLEAR AL)

Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Relapsed Or Refractory Al Amyloidosis trials by city

Relapsed Or Refractory Al Amyloidosis in Toronto Relapsed Or Refractory Al Amyloidosis in Vancouver Relapsed Or Refractory Al Amyloidosis in Montreal Relapsed Or Refractory Al Amyloidosis in Calgary Relapsed Or Refractory Al Amyloidosis in Edmonton Relapsed Or Refractory Al Amyloidosis in Ottawa Relapsed Or Refractory Al Amyloidosis in Winnipeg Relapsed Or Refractory Al Amyloidosis in Quebec City Relapsed Or Refractory Al Amyloidosis in Hamilton Relapsed Or Refractory Al Amyloidosis in Kitchener Relapsed Or Refractory Al Amyloidosis in London Relapsed Or Refractory Al Amyloidosis in Halifax Relapsed Or Refractory Al Amyloidosis in New York Relapsed Or Refractory Al Amyloidosis in Los Angeles Relapsed Or Refractory Al Amyloidosis in Chicago Relapsed Or Refractory Al Amyloidosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease